Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jagsonpal Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	3,158	2,872	2,687	2,087	2,367	2,176
Revenue Growth	11.71%	6.89%	28.76%	-11.83%	8.79%	15.77%
Gross Profit Gross Profit Growth	1,947	1,817	1,714	1,282	1,440	1,279
Operating Income Operating Income Growth	525.17	486.3	429.4	216.07	338.85	239.87
Net Income Net Income Growth	451.9	430.82	553.61	224.63	267.21	188.55
Earnings Per Share EPS Growth	6.67	6.31	8.22	3.39	4.08	2.88
EPS Growth	-27.36%	-23.18%	142.48%	-16.91%	41.72%	10.55%

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	2,870	2,652	2,040	2,312	2,122
Rest of The World Rest of The World Growth	2.63	34.96	46.61	55.28	54.26
Total Total Growth	2,872	2,687	2,087	2,367	2,176

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	1,153	1,058	1,285	1,479	1,146	470.57
Total Debt Total Debt Growth	92.16	81.65	92.39	89.41	60.01	-
Net Cash (Debt) Net Cash Growth	1,060	976.41	1,193	1,390	1,086	470.57
Net Cash Growth	-29.49%	-18.16%	-14.16%	27.96%	130.84%	-15.07%
Net Cash Per Share Net Cash Per Share Growth	15.64	14.31	17.72	20.96	16.59	7.18

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	476.02	468.12	551.13	351.66	466.55	69.14
Capital Expenditures CapEx Growth	-1.27	-1.48	-3.48	-2.48	-3.18	-10.49
Free Cash Flow Free Cash Flow Growth	474.75	466.64	547.65	349.18	463.37	58.65
Free Cash Flow Growth	18.48%	-14.79%	56.84%	-24.64%	690.06%	-78.87%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	61.68%	63.24%	63.77%	61.41%	60.84%	58.78%
Operating Margin	16.63%	16.93%	15.98%	10.35%	14.31%	11.02%
Pretax Margin	19.12%	20.03%	26.00%	14.31%	14.70%	12.24%
Profit Margin	14.31%	15.00%	20.60%	10.76%	11.29%	8.67%
FCF Margin	15.04%	16.25%	20.38%	16.73%	19.57%	2.70%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 12, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	2.500	2.500	2.500	2.000	2.000	1.600
Dividend Per Share Growth	60.00%	0%	25.00%	0%	25.00%	300.00%
Dividend Yield	1.15%	1.36%	1.15%	1.81%	1.73%	1.28%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 12, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	32.54	28.60	26.05	32.55	28.41	43.57
P/FCF Ratio	30.18	26.41	26.33	20.94	16.39	140.06
PS Ratio	4.54	4.29	5.37	3.50	3.21	3.78

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error